Published in J Immunol on May 15, 1997
Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice. Infect Immun (1998) 2.12
Persistence of Borrelia burgdorferi following antibiotic treatment in mice. Antimicrob Agents Chemother (2008) 2.02
Dual role of interleukin-10 in murine Lyme disease: regulation of arthritis severity and host defense. Infect Immun (1999) 1.91
Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14. Infect Immun (1999) 1.50
Exploitation of interleukin-8-induced neutrophil chemotaxis by the agent of human granulocytic ehrlichiosis. Infect Immun (2001) 1.36
CXCR2 blockade influences Anaplasma phagocytophilum propagation but not histopathology in the mouse model of human granulocytic anaplasmosis. Clin Diagn Lab Immunol (2004) 1.20
The pathogenesis of lyme neuroborreliosis: from infection to inflammation. Mol Med (2008) 1.20
The chemokine receptor CXCR2 ligand KC (CXCL1) mediates neutrophil recruitment and is critical for development of experimental Lyme arthritis and carditis. Infect Immun (2010) 1.19
Toll-like receptors: insights into their possible role in the pathogenesis of lyme neuroborreliosis. Infect Immun (2008) 1.10
Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway. Infect Immun (1998) 1.02
Viable Borrelia burgdorferi enhances interleukin-10 production and suppresses activation of murine macrophages. Infect Immun (2007) 1.01
Role of Fc gamma receptors in triggering host cell activation and cytokine release by Borrelia burgdorferi. Infect Immun (2001) 1.00
Borrelia burgdorferi and Treponema pallidum: a comparison of functional genomics, environmental adaptations, and pathogenic mechanisms. J Clin Invest (2001) 0.98
Beta2 integrins control the severity of murine Lyme carditis. Infect Immun (2005) 0.97
Human lipopolysaccharide-binding protein (LBP) and CD14 independently deliver triacylated lipoproteins to Toll-like receptor 1 (TLR1) and TLR2 and enhance formation of the ternary signaling complex. J Biol Chem (2013) 0.96
Lyme arthritis: current concepts and a change in paradigm. Clin Vaccine Immunol (2007) 0.94
Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and -infected mice. Clin Vaccine Immunol (2011) 0.91
Borrelia burgdorferi spirochetes induce mast cell activation and cytokine release. Infect Immun (1999) 0.87
Infectivity of the highly transformable BBE02- lp56- mutant of Borrelia burgdorferi, the Lyme disease spirochete, via ticks. Infect Immun (2006) 0.86
Anti-interleukin-15 prevents arthritis in Borrelia-vaccinated and -infected mice. Clin Vaccine Immunol (2006) 0.85
Complement receptor 3 binds the Borrelia burgdorferi outer surface proteins OspA and OspB in an iC3b-independent manner. Infect Immun (2005) 0.84
CXCL11 is involved in leucocyte recruitment to the central nervous system in neuroborreliosis. J Neurol (2005) 0.83
Presence of Arp specifically contributes to joint tissue edema associated with early-onset Lyme arthritis. Infect Immun (2013) 0.78
E and P selectins are not required for resistance to severe murine lyme arthritis. Infect Immun (1998) 0.77
Toll-like receptor cascade and gene polymorphism in host-pathogen interaction in Lyme disease. J Inflamm Res (2016) 0.76
The Cross-Talk between Spirochetal Lipoproteins and Immunity. Front Immunol (2014) 0.76
The Potential of Omics Technologies in Lyme Disease Biomarker Discovery and Early Detection. Infect Dis Ther (2016) 0.75
Spirochetal Lipoproteins and Immune Evasion. Front Immunol (2017) 0.75
Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques (1998) 11.39
Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol (2000) 6.68
Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci U S A (1984) 6.62
Herpes simplex virus type-1 glycoprotein D gene: nucleotide sequence and expression in Escherichia coli. Science (1982) 4.28
Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J Immunol (1999) 3.80
Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun (2001) 3.55
Restriction endonuclease and nucleotide sequence analyses of molecularly cloned unintegrated avian tumor virus DNA: structure of large terminal repeats in circle junctions. J Virol (1982) 3.02
Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues. Infect Immun (1994) 2.81
Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proc Natl Acad Sci U S A (1984) 2.71
Rapid and sensitive quantification of Borrelia burgdorferi-infected mouse tissues by continuous fluorescent monitoring of PCR. J Clin Microbiol (1999) 2.39
Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins. J Exp Med (1987) 2.28
Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect Immun (1993) 2.18
Intracellular localization of Borrelia burgdorferi within human endothelial cells. Infect Immun (1991) 2.13
Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice. Infect Immun (1998) 2.12
A complement receptor locus: genes encoding C3b/C4b receptor and C3d/Epstein-Barr virus receptor map to 1q32. J Immunol (1987) 1.94
Dual role of interleukin-10 in murine Lyme disease: regulation of arthritis severity and host defense. Infect Immun (1999) 1.91
Identification of a partial cDNA clone for the human receptor for complement fragments C3b/C4b. Proc Natl Acad Sci U S A (1985) 1.81
Evidence for B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice. Infect Immun (1992) 1.71
Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway. Infect Immun (1994) 1.66
Two steroid 21-hydroxylase genes are located in the murine S region. Nature (1985) 1.58
Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J Exp Med (1986) 1.56
Identification of quantitative trait loci governing arthritis severity and humoral responses in the murine model of Lyme disease. J Immunol (1999) 1.50
Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins. J Exp Med (1988) 1.48
Immunity to Lyme disease: protection, pathology and persistence. Curr Opin Immunol (1996) 1.48
Resistance to Lyme disease in decorin-deficient mice. J Clin Invest (2001) 1.46
Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement. Proc Natl Acad Sci U S A (1986) 1.42
Construction of E. coli expression plasmid libraries: localization of a pseudorabies virus glycoprotein gene. J Mol Appl Genet (1984) 1.41
Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA. Infect Immun (1994) 1.40
An immunologically active chimaeric protein containing herpes simplex virus type 1 glycoprotein D. Nature (1983) 1.40
Saliva of the tick Ixodes dammini inhibits neutrophil function. Exp Parasitol (1990) 1.38
The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. J Immunol (1998) 1.38
Resistance to phagocytosis by group A streptococci: failure of deposited complement opsonins to interact with cellular receptors. J Immunol (1985) 1.37
Murine M290 integrin expression modulated by mast cell activation. Immunity (1994) 1.36
Expression of the mouse fragilis gene products in immune cells and association with receptor signaling complexes. Genes Immun (2006) 1.35
Demonstration of a B-lymphocyte mitogen produced by the Lyme disease pathogen, Borrelia burgdorferi. Infect Immun (1992) 1.33
The expression of major histocompatibility antigens under metallothionein gene promoter control. J Immunol (1985) 1.32
Host-pathogen interactions promoting inflammatory Lyme arthritis: use of mouse models for dissection of disease processes. Curr Opin Microbiol (2001) 1.31
Borrelia burgdorferi outer membrane protein A induces nuclear translocation of nuclear factor-kappa B and inflammatory activation in human endothelial cells. J Immunol (1996) 1.30
The identification of N-linked oligosaccharides on the human CR2/Epstein-Barr virus receptor and their function in receptor metabolism, plasma membrane expression, and ligand binding. J Biol Chem (1985) 1.29
The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J Immunol (1990) 1.25
Development of a sensitive reverse transcriptase PCR assay, RT-RPCR, utilizing rapid cycle times. PCR Methods Appl (1992) 1.25
Bacterial synthesis of herpes simplex virus types 1 and 2 glycoprotein D antigens. J Invest Dermatol (1984) 1.23
The murine complement receptor gene family. Analysis of mCRY gene products and their homology to human CR1. J Immunol (1989) 1.19
Genetic control of susceptibility to experimental Lyme arthritis is polygenic and exhibits consistent linkage to multiple loci on chromosome 5 in four independent mouse crosses. Genes Immun (2001) 1.17
Molecular cloning of a cDNA that encodes the peptide core of a mouse mast cell secretory granule proteoglycan and comparison with the analogous rat and human cDNA. Proc Natl Acad Sci U S A (1989) 1.12
A single gene in mast cells encodes the core peptides of heparin and chondroitin sulfate proteoglycans. Proc Natl Acad Sci U S A (1986) 1.12
Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology. Infect Immun (1995) 1.11
Isolation and characterization of a cDNA that encodes the peptide core of the secretory granule proteoglycan of human promyelocytic leukemia HL-60 cells. J Biol Chem (1988) 1.05
The murine complement receptor gene family. III. The genomic and transcriptional complexity of the Crry and Crry-ps genes. J Immunol (1990) 1.02
Eucaryotic chromosome transfer: production of a murine-specific cosmid library from a neor-linked fragment of murine chromosome 17. Mol Cell Biol (1986) 1.02
Expression of hemolytically active murine fourth component of complement in transfected L cells. Cell (1984) 0.99
Eukaryotic chromosome transfer: linkage of the murine major histocompatibility complex to an inserted dominant selectable marker. Proc Natl Acad Sci U S A (1984) 0.96
Expansion of the complement receptor gene family. Identification in the mouse of two new genes related to the CR1 and CR2 gene family. J Immunol (1987) 0.95
Metaphase chromosome transfer of introduced selectable markers. J Mol Appl Genet (1984) 0.95
Purification of the B lymphocyte receptor for the C3d fragment of complement and the Epstein-Barr virus by monoclonal antibody affinity chromatography, and assessment of its functional capacities. J Immunol Methods (1986) 0.93
Cell-specific regulation of the CD21 gene. Int Immunopharmacol (2001) 0.92
The role of receptors for complement in the induction of polyclonal B-cell proliferation and differentiation. J Clin Immunol (1986) 0.92
Expression of murine beta 7, alpha 4, and beta 1 integrin genes by rodent mast cells. J Immunol (1992) 0.92
Polymerase chain reaction detection of Lyme disease: correlation with clinical manifestations and serologic responses. Am J Clin Pathol (1996) 0.91
Preferential expression of interleukin-12 or interleukin-4 by murine bone marrow mast cells derived in mast cell growth factor or interleukin-3. Eur J Immunol (1994) 0.90
Mucosal T cells and mast cells share common adhesion receptors. Immunol Today (1996) 0.90
Genetic organization of complement receptor-related genes in the mouse. J Exp Med (1989) 0.90
Loss of human CR1- and murine Crry-like exons in human CR2 transcripts due to CR2 gene mutations. J Immunol (1990) 0.89
Variability of CR2 gene products is due to alternative exon usage and different CR2 alleles. J Immunol (1989) 0.89
Murine complement receptor gene family. II. Identification and characterization of the murine homolog (Cr2) to human CR2 and its molecular linkage to Crry. J Immunol (1989) 0.88
Structure and thermodynamics of a two-dimensional Coulomb fluid in the strong association regime. J Chem Phys (2007) 0.88
DNA topoisomerase activity associated with Rous sarcoma virus. Virology (1981) 0.87
Microphthalmic mice display a B cell deficiency similar to that seen for mast and NK cells. J Immunol (1999) 0.87
Defining a transcriptional fingerprint of murine splenic B-cell development. Genes Immun (2008) 0.86
Expression of the murine CD21 gene is regulated by promoter and intronic sequences. J Immunol (1997) 0.86
Isolation of a cDNA that encodes the peptide core of the secretory granule proteoglycan of rat basophilic leukemia-1 cells and assessment of its homology to the human analogue. J Biol Chem (1988) 0.86
Interleukin-4 (IL-4) and IL-13 signaling pathways do not regulate Borrelia burgdorferi-induced arthritis in mice: IgG1 is not required for host control of tissue spirochetes. Infect Immun (2000) 0.85
Functional characterization of Pactolus, a beta-integrin-like protein preferentially expressed by neutrophils. J Biol Chem (2001) 0.84
Lymphoid transcription of the murine CD21 gene is positively regulated by histone acetylation. J Immunol (1999) 0.83
Modulation of integrin expression during mast cell differentiation. Eur J Immunol (1992) 0.83
Differential expression of H-2Dd and H-2Ld histocompatibility antigens. J Exp Med (1985) 0.83
Modulation of expression of the anti-inflammatory cytokines interleukin-13 and interleukin-10 by interleukin-3. Eur J Immunol (1996) 0.81
Identification of sites for distinct DNA binding proteins including Oct-1 and Oct-2 in the Cr2 gene. J Immunol (1992) 0.81
Overexpression of RANKL implicates IFN-beta-mediated elimination of B-cell precursors in the osteopetrotic bone of microphthalmic mice. J Bone Miner Res (2003) 0.81
CD28 expression by mouse mast cells is modulated by lipopolysaccharide and outer surface protein A lipoprotein from Borrelia burgdorferi. J Immunol (1997) 0.81